A two-page summary on newly marketed drugs including the therapeutic classification, indications, pharmacology and pharmacokinetics, summary of clinical trials, reactions and interactions, dosing, comparative cost and place in therapy. This publication is issued up to 24 times per year.
Sample publication of a Drug Evaluation
Below are the titles of this publication issued in 2009.
|
Doripenem |
December 2009 |
||
|
Methyl Aminolevulinate Hydrochloride (Aktinic keratoses & Basal Cell Carcinoma) |
November 2009 |
||
|
Epelrenone |
October 2009 |
||
|
Ethinyl estradiol/Drospirenone (Yaz®) |
September 2009 |
||
|
Zoster Vaccine |
August 2009 |
||
|
Loteprednol Etabonate 0.5% |
July 2009 |
||
|
Loteprednol Etabonate 0.2% |
June 2009 |
||
|
Desvenlafaxine Succinate |
May 2009 |
||
|
Ciclesonide Nasal Spray |
April 2009 |
||
|
Ustekinumab Injection |
March 2009 |
||
|
Olmesartan Medoxomil & Olmesartan Medoxomil/Hydrochlorothiazide |
February 2009 |
||
|
Insulin Glulisine |
January 2009 |